Psyence Biomedical LTD. (PBMWW) — 20-F Filings
All 20-F filings from Psyence Biomedical LTD.. Browse 3 Foreign Annual Report reports with AI-powered summaries and risk analysis.
20-F Filings (3)
-
Psyence Biomedical Posts $10.5M Loss Amid Clinical Trial Push
— Jun 25, 2025 Risk: high
PSYENCE BIOMEDICAL LTD. reported no revenue for the fiscal year ended March 31, 2025, consistent with its pre-commercialization stage. The company incurred a ne -
Psyence Biomedical Ltd. Files 20-F Report
— Jul 29, 2024 Risk: medium
Psyence Biomedical Ltd. filed its 20-F report for the period ending March 31, 2024. The company, incorporated in A6 and headquartered in Toronto, operates in th -
Psyence Biomedical Ltd. Files Annual Report on Form 20-F
— Jan 31, 2024 Risk: low
PSYENCE BIOMEDICAL LTD. (PBMWW) filed a Foreign Annual Report (20-F) with the SEC on January 31, 2024. Psyence Biomedical Ltd. filed a Form 20-F on January 31,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX